Traditional risk factors for cardiovascular disease can only assess risks for groups of people. New parameters of arterial stiffness are more reliable for predicting cardiovascular outcomes for individuals with and wi...Traditional risk factors for cardiovascular disease can only assess risks for groups of people. New parameters of arterial stiffness are more reliable for predicting cardiovascular outcomes for individuals with and without a cardiovascular history. The objective of this study was to assess the effects of Magnesium-EDTA chelation therapy using new methods and parameters such as pulse wave velocity (PWV), central blood pressure (SBPao) and endothelial function (Aix). We followed 43 patients with an abnormal PWV and SBPao, setting them up in two groups. The 21 patients in Group A had already been diagnosed with cardiovascular disease. The other 22 patients in Group B also showed abnormal PWV, SBPao and Aix, but showed no cardiovascular symptoms. Each patient in Groups A and B received one Mg-EDTA treatment per week. The total treatment plan consisted of 25 Mg-EDTA chelation treatments according to the standard protocol of IBCMT. After 25 Mg-EDTA chelation sessions, PWV and SBPao improved significantly in all patients of Groups A and B. In addition, Aix improved significantly in these patients, but remained abnormal. Group C included 18 asymptomatic patients with normal PWV or SBPao. Aix was abnormal in this group, but to a much lesser extent than Groups A and B. The 18 asymptomatic patients of Group C did not receive Mg-EDTA treatment. Observation showed no significant changes in all three parameters of arterial stiffness. The results of this study indicate that a course of treatment with Magnesium-EDTA chelation therapy significantly lowers cardiovascular risks. We conclude that Mg-EDTA chelation therapy improves PWV as an indicator of arterial stiffness, SBPao (central blood pressure) as an indicator of aortic elasticity and Aix (augmented aortic index) as an indicator of endothelial functioning. These improvements in PWV, SBPao and Aix demonstrate that atherosclerosis is a dynamic and (partially) reversible process.展开更多
将AZ31镁合金在NaOH、Na2SiO3和Na2B4O7的电解液中进行阳极氧化,考察了乙二胺四乙酸添加剂对阳极氧化膜性能的影响。用扫描电镜观察阳极氧化膜形貌,用X-射线衍射和自带能谱仪对膜层的相组织和元素含量进行分析,用交流阻抗测试氧化膜的...将AZ31镁合金在NaOH、Na2SiO3和Na2B4O7的电解液中进行阳极氧化,考察了乙二胺四乙酸添加剂对阳极氧化膜性能的影响。用扫描电镜观察阳极氧化膜形貌,用X-射线衍射和自带能谱仪对膜层的相组织和元素含量进行分析,用交流阻抗测试氧化膜的耐蚀性能。结果表明,氧化膜主要由Mg O组成,膜层中出现了乙二胺四乙酸的特征元素C和N,Mg Si O3的衍射峰受到抑制。阳极氧化过程中的起弧电压随乙二胺四乙酸含量的增加呈上升的变化趋势。随着乙二胺四乙酸含量的增加,膜层耐蚀性先提高后降低。乙二胺四乙酸质量浓度为7.5 g/L时氧化膜具有最大的阻抗,最优的耐蚀性能。展开更多
文摘Traditional risk factors for cardiovascular disease can only assess risks for groups of people. New parameters of arterial stiffness are more reliable for predicting cardiovascular outcomes for individuals with and without a cardiovascular history. The objective of this study was to assess the effects of Magnesium-EDTA chelation therapy using new methods and parameters such as pulse wave velocity (PWV), central blood pressure (SBPao) and endothelial function (Aix). We followed 43 patients with an abnormal PWV and SBPao, setting them up in two groups. The 21 patients in Group A had already been diagnosed with cardiovascular disease. The other 22 patients in Group B also showed abnormal PWV, SBPao and Aix, but showed no cardiovascular symptoms. Each patient in Groups A and B received one Mg-EDTA treatment per week. The total treatment plan consisted of 25 Mg-EDTA chelation treatments according to the standard protocol of IBCMT. After 25 Mg-EDTA chelation sessions, PWV and SBPao improved significantly in all patients of Groups A and B. In addition, Aix improved significantly in these patients, but remained abnormal. Group C included 18 asymptomatic patients with normal PWV or SBPao. Aix was abnormal in this group, but to a much lesser extent than Groups A and B. The 18 asymptomatic patients of Group C did not receive Mg-EDTA treatment. Observation showed no significant changes in all three parameters of arterial stiffness. The results of this study indicate that a course of treatment with Magnesium-EDTA chelation therapy significantly lowers cardiovascular risks. We conclude that Mg-EDTA chelation therapy improves PWV as an indicator of arterial stiffness, SBPao (central blood pressure) as an indicator of aortic elasticity and Aix (augmented aortic index) as an indicator of endothelial functioning. These improvements in PWV, SBPao and Aix demonstrate that atherosclerosis is a dynamic and (partially) reversible process.
文摘将AZ31镁合金在NaOH、Na2SiO3和Na2B4O7的电解液中进行阳极氧化,考察了乙二胺四乙酸添加剂对阳极氧化膜性能的影响。用扫描电镜观察阳极氧化膜形貌,用X-射线衍射和自带能谱仪对膜层的相组织和元素含量进行分析,用交流阻抗测试氧化膜的耐蚀性能。结果表明,氧化膜主要由Mg O组成,膜层中出现了乙二胺四乙酸的特征元素C和N,Mg Si O3的衍射峰受到抑制。阳极氧化过程中的起弧电压随乙二胺四乙酸含量的增加呈上升的变化趋势。随着乙二胺四乙酸含量的增加,膜层耐蚀性先提高后降低。乙二胺四乙酸质量浓度为7.5 g/L时氧化膜具有最大的阻抗,最优的耐蚀性能。
